Open access · CC-BY
via OpenAlex
A Small Molecule That Promotes Cellular Senescence Prevents Fibrogenesis and Tumorigenesis
Moon Kee Meang, Saesbyeol Kim, Ik Hwan Kim, Han-Soo Kim, Byung‐Soo Youn
International Journal of Molecular Sciences · 2022 · ▲ 3 citations
Abstract
Uncontrolled proliferative diseases, such as fibrosis or cancer, can be fatal. We previously found that a compound containing the chromone scaffold (CS), ONG41008, had potent antifibrogenic effects associated with EMT or cell-cycle control resembling tumorigenesis. We investigated the effects of ONG41008 on tumor cells and compared these effects with those in pathogenic myofibroblasts. Stimulation of A549 (lung carcinoma epithelial cells) or PANC1 (pancreatic ductal carcinoma cells) with ONG41008 resulted in robust cellular senescence(definition), indicating that dysregulated cell proliferation is common to fibrotic cells and tumor cells. The senescence was followed by multinucleation, a manifestation of mitotic slippage. There was significant upregulation of expression and rapid nuclear translocation of p-TP53 and p16 in the treated cancer cells, which thereafter died after 72 h confirmed by 6 day live imaging. ONG41008 exhibited a comparable senogenic potential to that of dasatinib. Interestingly, ONG41008 was only able to activate caspase-3, 7 in comparison with quercetin and fisetin, also containing CS in PANC1. ONG41008 did not seem to be essentially toxic to normal human lung fibroblasts or primary prostate epithelial cells, suggesting ONG41008 can distinguish the intracellular microenvironment between normal cells and aged or diseased cells. This effect might occur as a result of the increased NAD/NADH ratio, because ONG41008 restored this important metabolic ratio in cancer cells. Taken together, this is the first study to demonstrate that a small molecule can arrest uncontrolled proliferation during fibrogenesis or tumorigenesis via both senogenic and senolytic potential. ONG41008 could be a potential drug for a broad range of fibrotic or tumorigenic diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms23126852
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Meang, M.K., Kim, S., Kim, I.H., Kim, H., & Youn, B. (2022). A Small Molecule That Promotes Cellular Senescence Prevents Fibrogenesis and Tumorigenesis. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms23126852
Vancouver
Meang MK, Kim S, Kim IH, Kim H, Youn B. A Small Molecule That Promotes Cellular Senescence Prevents Fibrogenesis and Tumorigenesis. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms23126852.
BibTeX
@article{moon2022ASmall,
title = {A Small Molecule That Promotes Cellular Senescence Prevents Fibrogenesis and Tumorigenesis},
author = {Moon Kee Meang and Saesbyeol Kim and Ik Hwan Kim and Han-Soo Kim and Byung‐Soo Youn},
journal = {International Journal of Molecular Sciences},
year = {2022},
doi = {10.3390/ijms23126852},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
FEBS Journal 2022
Open access · OA
The role of cellular senescence and SASP in tumour microenvironment
European Respiratory Journal 2017
Open access · CC-BY
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Cancer Research 2007
Open access · OA
Meeting Report: Mitochondrial DNA and Cancer Epidemiology
Human Reproduction Update 2017
Open access · OA
Genetic and epigenetic factors which modulate differentiation propensity in human pluripotent stem cells
Acta Biochimica Indonesiana 2021
Open access · CC-BY
The role of senescence-associated secretory phenotype (SASP) in cellular senescene
Stem Cells International 2022
Open access · CC-BY